Recent Updates
Recently added Catalysts
VOR Positive Sentiment Score: 75/100

Vor Bio to Participate in Upcoming Investor Conferences

Wednesday, August 30, 2023 1 min read
Key Takeaway: Vor Bio (Nasdaq: VOR) has announced its participation in several upcoming investor conferences including Citi's 2023 BioPharma Conference, the H.C. Wainwright Global Investment Conference, and Baird's Global Healthcare Conference. These events will provide platforms for Vor Bio to present its clinical-stage developments and its mission to enhance treatment standards for blood cancer patients through advanced cell and genome engineering techniques. Presentations will be held both in person and virtually, and recordings will be made available on their investor website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Vor Bio is participating in multiple prestigious investor conferences.
  • The company is showcasing its innovative approach to treating blood cancers.
  • Live webcasts of presentations will be accessible, increasing investor transparency.

Full Press Release Details

CAMBRIDGE, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:
Citi’s 2023 18th Annual BioPharma Conference
1x1 Investor Meetings: Thursday, September 7, 2023
Location: Four Seasons Hotel, Boston, MA
H.C. Wainwright 25th Annual Global Investment Conference (Hybrid)
Virtual Presentation: Monday, September 11, 2023
Location: Lotte New York Palace Hotel, New York, NY
Baird’s 2023 Global Healthcare Conference
Presentation: Wednesday, September 13, 2023 at 9:05 am ET
Location: Intercontinental New York Barclay, New York, NY
Morgan Stanley 21st Annual Global Healthcare Conference
Fireside Chat: Wednesday, September 13, 2023 at 4:15 pm ET
Location: Sheraton Hotel, New York, NY
Live webcasts and archived replays of the presentation at the H.C. Wainwright 25th Annual Global Investment Conference and the fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference will be available on the investors section of www.vorbio.com.
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Frequently Asked Questions

What conferences will Vor Bio attend in September 2023?

Vor Bio will attend the Citi’s BioPharma Conference, H.C. Wainwright Conference, Baird Healthcare Conference, and Morgan Stanley Conference.

Where is the Citi’s BioPharma Conference located?

The Citi’s BioPharma Conference is at the Four Seasons Hotel in Boston, MA.

When will Vor Bio's presentation be at the Baird Healthcare Conference?

Vor Bio's presentation at the Baird Healthcare Conference is on September 13, 2023, at 9:05 am ET.

How can I watch Vor Bio's presentations online?

Live webcasts and archived replays will be available on the investors section of their website.

What is Vor Bio's main focus?

Vor Bio focuses on changing the standard of care for blood cancer patients through genome engineering.

Tags: VOR Viatris Investor Conferences Healthcare Vor Bio blood cancers investor conferences bio-pharma
Last updated: Aug 30, 2023